Schmitt, A <br/><br/>
IGFII and MIB1 immunohistochemistry is helpful for the differentiation of benign from malignant adrenocortical tumours.  [electronic resource] 

 -  Histopathology  Sep 2006 
 - 298-307 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0309-0167 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2559.2006.02505.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenal Cortex Neoplasms--diagnosis<br/>Adrenocortical Adenoma--diagnosis<br/>Adrenocortical Carcinoma--diagnosis<br/>Adult<br/>Aged<br/>Biomarkers, Tumor--analysis<br/>Cyclin-Dependent Kinase 4--biosynthesis<br/>Diagnosis, Differential<br/>Golgi Apparatus--metabolism<br/>Humans<br/>Immunohistochemistry<br/>Insulin-Like Growth Factor Binding Protein 2--biosynthesis<br/>Ki-67 Antigen--biosynthesis<br/>Middle Aged<br/>Sensitivity and Specificity<br/>Tumor Suppressor Protein p53--biosynthesis